Beijing Chunlizhengda Medical Instruments (1858.HK) Earnings Analysis
Beijing Chunlizhengda Medical Instruments (1858.HK) next reports earnings on 2026-08-29. It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E 19.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1858.HK next report earnings?
| Next earnings date | 2026-08-29 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.25B |
1858.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 0.1818 HKD | n/a | n/a | n/a |
| 2026-02-27 | 0.2114 HKD | n/a | n/a | n/a |
| 2025-10-30 | 0.2186 HKD | n/a | n/a | n/a |
| 2025-08-29 | 0.1641 HKD | n/a | n/a | n/a |
| 2025-02-27 | 0.1809 HKD | 0.3512 HKD | -48.5% | Miss |
| 2024-08-30 | 0.07152 HKD | 0.2579 HKD | -72.3% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
1858.HK valuation and analyst view
| Trailing P/E | 19.24 |
|---|---|
| Trailing EPS | 0.72153 HKD |
| Price / book | 1.74 |
| Dividend yield | 1.44% |
| Market cap | 5.20B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing Chunlizhengda Medical Instruments (1858.HK)'s next earnings date?
Beijing Chunlizhengda Medical Instruments is next scheduled to report on 2026-08-29 and revenue estimate of 0.25B.
Did 1858.HK beat earnings last quarter?
Consensus estimate data was not available for 1858.HK's 2026-04-29 report.
What is 1858.HK's earnings track record?
Over the last 2 reported quarters with consensus data, 1858.HK beat estimates 0 times (0%).
What is 1858.HK's current P/E ratio and EPS?
1858.HK trades at a trailing P/E of 19.24 on trailing EPS of 0.7215347109795169 HKD.
What do analysts rate 1858.HK?
1858.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.